Abstract
A lasting legacy of a fetus to the mother is a small number of stably persistent allogeneic cells; the phenomenon known as fetal microchimerism. Prior studies demonstrated that fetal microchimerism in the peripheral blood is associated with protection from breast cancer. Whether the same association of fetal microchimerism extends to the tissue of interest, the breast, is unknown. Total genomic DNA was extracted from frozen normal breast tissue adjacent to invasive disease in women with breast cancer. Control DNA was extracted from reduction mammoplasty tissues from women with no prior history of any breast cancer. The presence of male DNA, presumably from a prior male fetus, was determined with a quantitative PCR assay for the Y chromosome gene, DYS14. Proportions of tissues harboring fetal microchimerism were compared. Thirty-eight cancer-free breast tissues from women with and without a history of breast cancer were evaluable for the presence and quantity of fetal microchimerism testing with the DYS14 assay. Breast tissue from women free of cancer harbored FMc more frequently than normal breast tissue adjacent to invasive disease in women with breast cancer (63 and 26%, respectively). The odds ratio, corrected for total DNA quantity tested, for this protective association of fetal microchimerism against breast cancer was 0.17 (95% confidence interval 0.04–0.76). Findings indicate that the protective association of fetal microchimerism against breast cancer observed previously in the peripheral blood is also reflected in breast tissue.
References
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93:705–708
Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, Erickson TD, Nelson JL (2203) Male DNA in female donor apheresis and CD34-enriched products. Blood 102:3845–3847
Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW (2004) Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 292:75–80
Adams KM, Nelson JL (2004) Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291:1127–1131
Gadi VK, Nelson JL (2007) Fetal microchimerism in women with breast cancer. Cancer Res 67:9035–9038
Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL (2008) Case-control study of fetal microchimerism and breast cancer. PLoS One 3:e1706
Gilmore GL, Haq B, Shadduck RK, Jasthy SL, Lister J (2008) Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Exp Hematol 36:1073–1077
Cirello V, Recalcati MP, Muzza M, Rossi S, Perrino M, Vicentini L, Beck-Peccoz P, Finelli P, Fugazzola L (2008) Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res 68:8482–8488
Dubernard G, Aractingi S, Oster M, Rouzier R, Mathieu MC, Uzan S, Khosrotehrani K (2008) Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res 10:R14
Cha D, Khosrotehrani K, Kim Y, Stroh H, Bianchi DW, Johnson KL (2003) Cervical cancer and microchimerism. Obstet Gynecol 102:774–781
Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, Nelson JL (2002) Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 100:2845–2851
Gadi VK (2009) Fetal microchimerism and cancer. Cancer Lett 276:8–13
Acknowledgments
The author thanks Peggy Porter, MD, and Barbara Stein, PhD, for providing specimens from the Breast Specimen Repository at the Fred Hutchinson Cancer Research Center; Ara D. Walline, BA, for performing DNA extractions and quantitative PCR; and Hilary Gammill, MD, for assisting with statistical analyses. This research was supported by Mary Kay Ash Charitable Foundation and Expedition Inspiration Fund for Breast Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gadi, V.K. Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat 121, 241–244 (2010). https://doi.org/10.1007/s10549-009-0548-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-009-0548-1